Conflict of interest declaration: Katrina Williams

Updated on: 15 February 2021

Roles in: Developmental, Psychosocial and Learning Problems Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the CRG?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
Yes - There has been contracts between the Murdoch Children's Research Institute for interventional produce and placebo with Tilray and THC Pharma for cannabinoid trials for children with intellectual disability, with or without autism, and severe behaviour disorder.

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty or licences payments?
Yes - I receive royalties for a book called "Understanding autism. The essential guide for parents" that I co-authored with Prof J Roberts. The book provides broad advice for parents about autism. The company is Exisle publishing

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the CRG?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the CRG?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the CRG?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - I provided advice for a fee about the effectiveness of melatonin for improving sleep in children with a rare condition or autism. This advice was provided once to a committee as a presentation to assist their deliberations and decision making. The committee is part of the Therapeutic Goods Administration of Australia, a government organisation responsible for regulating therapeutic goods including prescription medicines. I was also an unpaid member of the data monitoring committee for one pharmacological trial of SSRIs (selective serotonin reuptake inhibitors) for repetitive behaviours in children with ASD, which was funded by the National Health and Medical Research Council and from donations from the Royal Children's Hospital Foundation. This role was with the Murdoch Children's Research Institute I had a contract with an Australian state education department to review their data about autism and other neurodevelopmental differences.